bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Hypersensitivity
Bites and Stings
Emergencies
First Aid
Environment
 Resources from HONselect
Shortage of Bee, Wasp Venom Stings Those With Allergies
Facing expected season-long shortage, doctors urge patients to carry EpiPens just in case

By Robert Preidt

FRIDAY, July 7, 2017 (HealthDay News) -- A shortage of honeybee, wasp and hornet venom extract has allergists concerned.

The extract treats people who have potentially life-threatening allergies to stings by these insects. It is given in immunotherapy shots to help build up tolerance to the stings.

Manufacturing problems at one of two companies that produce the extract has reduced the U.S. supply by up to 35 percent, according to CNN.

The shortage is expected to continue through the summer -- peak sting season, researchers warned.

"Allergy immunotherapy is one of the best therapies that we have. This treatment can be protective in 99 percent of patients. So, for those patients who cannot be treated or whose treatment is delayed, it's scary and they may limit their levels of outdoor activity," said Dr. Juan Guarderas. He is an allergist-immunologist at University of Florida Health Allergy in Gainesville.

Despite the shortage, patients are still getting treatment, the allergy specialists noted in a university news release.

Dr. Mario Rodenas-Medina said that "there's no need to panic. Patient care has not been affected. We just need to be aware that there are resources despite the shortage." He is a clinical assistant professor of allergy and clinical immunology at the UF College of Medicine.

Patients who are allergic should keep up-to-date epinephrine injectors (EpiPens) handy, the doctors advised.

The American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology recommend reducing maintenance doses of the extracts, increasing time between shots and delaying treatment for patients at the lowest risk of a bad reaction.

"We have to be diligent and we have to be careful about misuse of these extracts because they're highly valuable right now," Rodenas-Medina said.

More information

The U.S. Food and Drug Administration has more on bug bites and stings.

SOURCE: University of Florida, news release, July 3, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=724314

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Bites and Stings
Hypersensitivity
Venoms
Therapeutics
Asthma
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact